Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Access to hospital-based eye care and reimbursement were policy topics at the…
Phase 2 data for kamuvudine K8, an investigational inflammasome-directed treatment from Inflammasome…
Two transactions announced in September and October 2026 show capital moving through…
GenSight Biologics and the Quinze-Vingts National Ophthalmology Hospital in Paris announced on…
This segment reviews a case-based roundtable discussion focused on advanced intraocular lens…
This segment explores real-world approaches to loading dose protocols and dosing interval…
(Image Credit: AdobeStock/ImageFlow) Artificial intelligence (AI) continues to evolve with improved diagnostic…
(Image Credit: AdobeStock/Chris Tefme) With dry eye disease (DED) presenting ongoing challenges…
The US Food and Drug Administration (FDA) approved aflibercept 8 mg (EYLEA…
(Image Credit: AdobeStock/artacet) In recent years, gene therapy has emerged from the…
Advances in topical therapies highlight new approaches to supporting corneal healing and…
(Image Credit: AdobeStock/NINENII) An online tool, Atrophy Advisor, was developed to guide…
(Image Credit: AdobeStock) Demodex blepharitis is more common than previously thought, and…
Enter your email address below and subscribe to our newsletter